Figure 2From: SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experienceAverage cumulative DVH over the patient population (solid line), inter-patient variability is expressed at 1 standard deviation (dashed lines); a: CTV and PTV for patients treated at 36Gy; b: CTV and PTV for patients treated at 45Gy; c: OARs, irrespective of the dose prescription.Back to article page